A Study to Assess the Efficacy and Safety of HSK31858 in Participants With Non-Cystic Fibrosis Bronchiectasis

NCT06660992 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

669

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-cystic Fibrosis Bronchiectasis

Interventions

DRUG: HSK31858, tablet
DRUG: Placebo

Sponsor

Haisco Pharmaceutical Group Co., Ltd.